Q1 2015 13F Holders as of 3/31/2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
295M
-
Number of holders
-
165
-
Total 13F shares, excl. options
-
51M
-
Shares change
-
+3.48M
-
Total reported value, excl. options
-
$799M
-
Value change
-
+$55.4M
-
Put/Call ratio
-
0.08
-
Number of buys
-
89
-
Number of sells
-
-68
-
Price
-
$15.68
Significant Holders of SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) as of Q1 2015
200 filings reported holding SGMO - SANGAMO THERAPEUTICS, INC - Common Stock as of Q1 2015.
SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) has 165 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 51M shares
of 295M outstanding shares and own 17.3% of the company stock.
Largest 10 shareholders include FMR LLC (4.22M shares), WASATCH ADVISORS INC (3.06M shares), BlackRock Fund Advisors (2.61M shares), STATE STREET CORP (2.52M shares), VANGUARD GROUP INC (2.26M shares), FRONTIER CAPITAL MANAGEMENT CO LLC (2.17M shares), BlackRock Institutional Trust Company, N.A. (1.91M shares), Bank of New York Mellon Corp (1.77M shares), JANUS CAPITAL MANAGEMENT LLC (1.76M shares), and JENNISON ASSOCIATES LLC (1.72M shares).
This table shows the top 165 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.